✦ LIBER ✦

Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis

✍ Scribed by H. Türktaş; M. Ünsal; N. Tülek; O. Örüç

Book ID: 113405565
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 380 KB
Volume: 75
Category: Article
ISSN: 0962-8479
DOI: 10.1016/0962-8479(94)90104-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum enzyme changes in patients receivi

Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin

✍ D.N. Baron; Joyce L. Bell 📂 Article 📅 1974 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Potentiation of isoniazid-induced liver

Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in Wistar rats: A toxicity profile study

✍ Sheikh Abdullah Tasduq; Peerzada Kaiser; Subhash Chander Sharma; Rakesh Kamal Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

Hepatic toxicity in south indian patient

Hepatic toxicity in south indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide

✍ R. Parthasarathy; G.Raghupati Sarma; B. Janardhanam; Padma Ramachandran; T. Sant 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 893 KB

A prospective clinical study of isoniazi

A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B

✍ SHINN-JANG HWANG; JAW-CHING WU; CHUN-NIN LEE; FU-SHUN YEN; CHING-LIANG LU; TAO-P 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

Optimization of a reversed-phase-high-pe

Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets

✍ Shewiyo, D.H.; Kaale, E.; Risha, P.G.; Dejaegher, B.; Smeyers-Verbeke, J.; Vande 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Therapy of hepatitis B — Viral suppressi

Therapy of hepatitis B — Viral suppression or eradication?

✍ Robert P. Perrillo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## **The practicing clinician is currently faced with a number of treatment options for chronic hepatitis B. Beginning in 1998 with the licensing of lamivudine and subsequently adefovir, the treatment paradigm shifted from 4 to 6 months of conventional alfa interferon to a year of nucleoside analo